Pharma Mar | PHM - Cost Of Sales

Stock Price
80.25
Daily Change
1.20 1.52%
Monthly
1.71%
Yearly
-16.23%
Q1 Forecast
77.09

Pharma Mar reported EUR2.3M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 8.13M 2.41M Mar/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 191.5M 2.29M Dec/2025
Avita Medical AUD 3.47M 1.19M Jun/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Pharma Mar EUR 2.3M 477K Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025